Pharmaceutical compounds, namely, chemical, biochemical and biological compounds, from targeting Guanine nucleotide exchange factors ("GEF"s) in the insilico pharmacological method, for use as biological tools in pharmaceutical research, and pharmaceutical product discovery and development; pharmaceutical compounds, namely, chemical, biochemical and biological compounds, from targeting Guanine nucleotide exchange factors ("GEF"s) in the insilico screening pharmacological method, for use as biological tools in research and development in targeting biological agents involved in human diseases; pharmaceutical compounds, namely, synthetic molecules, from targeting Guanine nucleotide exchange factors ("GEF"s) in the in silico screening pharmacological method, for research and development as drug candidates

Biological tools in the nature of pharmaceutical compounds from targeting Guanine nucleotide exchange factors ("GEF"s) in the insilico screening pharmacological method, being components of medical diagnostic preparations and formulations, namely, chemical, biochemical, and biological compounds targeting biological agents associated with human disease and illness; biological tools in the nature of pharmaceutical compounds developed from targeting Guanine nucleotide exchange factors ("GEF"s) in the in silico screening pharmacological method, for treating cancers and diseases, namely, cardiovascular, inflammation, diabetes and neurological diseases

Biomedical services, namely, research, development, and product design for pharmaceutical products involved in the diagnosis and treatment of human diseases; Biomedical services, namely, pharmaceutical research and development, modeling and testing of pharmaceuticals and cancer diagnostic and treatment therapies; Biomedical and Laboratory services, namely, biologic assay development, preclinical pharmaceutical research, clinical research, clinical trial management, and providing in silico screening and in vitro testing of small molecules targeting Guanine nucleotide exchange factors ("GEF"s), all for pharmaceutical product research, discovery, and development purposes; consulting and advising on scientific research in the fields of small molecules and drug discovery